Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · IEX Real-Time Price · USD
5.85
+0.04 (0.69%)
At close: Jul 19, 2024, 4:00 PM
5.77
-0.08 (-1.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $6.10 million as of July 22, 2024. Its market cap has decreased by -54.11% in one year.
Market Cap
6.10M
Enterprise Value
-5.87M
1-Year Change
-54.11%
Ranking
Category
Stock Price
$5.85
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $6.10M, a decrease of -90.65%. That is a compound annual growth rate of -56.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 6.10M | -20.78% |
| Dec 29, 2023 | 7.70M | -59.04% |
| Dec 30, 2022 | 18.80M | -51.42% |
| Dec 31, 2021 | 38.70M | -40.73% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 6.69M |
| Telesis Bio | 6.69M |
| Xenetic Biosciences | 6.41M |
| Chromocell Therapeutics | 6.40M |
| ReShape Lifesciences | 6.21M |
| CareMax | 6.01M |
| SunLink Health Systems | 6.00M |
| Soligenix | 5.99M |